Skip to main content

Table 3 CyPath lung performance

From: Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning

 

LSRII

LSRII (nodules all < 20 mm)

Navios

Total samples

150

132

32

Cancer

28

13

6

Non-cancer

122

119

26

Sensitivity (95% CI)

0.82 (0.64–0.92)

0.92 (0.67–0.99)

0.83 (0.44–0.97)

Specificity (95% CI)

0.88 (0.81–0.92)

0.87 (0.80–0.92)

0.77 (0.58–0.89)

Accuracy (95% CI)

0.87(0.80–0.91)

0.88 (0.81–0.92)

0.78 (0.61–0.89)

Area under ROC curve (95% CI)

0.89 (0.83–0.96)

0.94 (0.89–0.99)

0.85 (0.71–0.98)

Positive predictive value (95% CI)

   

 Cancer prevalence in data set

0.61 (0.48–0.72)

0.44 (0.33–0.57)

0.45 (0.27–0.65)

 Prevalence reported in high-riska

0.05 (0.03–0.09)

0.06 (0.04–0.92)

0.03 (0.01–0.06)

 Prevalence in LDCT positiveb

0.17 (0.11–0.25)

0.18 (0.12–0.26)

0.10 (0.05–0.19)

Negative predictive value (95% CI)

   

 Cancer prevalence in data set

0.96 (0.91–0.98)

0.99 (0.94–1.00)

0.95 (0.77–0.99)

 Prevalence reported in high-riska

1.00 (1.00–1.00)

1.00 (1.00–1.00)

1.00 (1.00–1.00)

 Prevalence in LDCT positiveb

0.99 (0.99–1.00)

1.00 (0.98–1.00)

0.99 (0.96–1.00)

Positive diagnostic likelihood ratio (PDLR)c

6.31

7.08

3.61

  1. a0.83% cancer prevalence in NLST 2013 [1]
  2. b2.9% cancer prevalence in NLST 2013 LDCT positive cases only
  3. cSensitivity/(1 − specificity) see Pepe et al. [37]
  4. Wilson confidence intervals (CIs) for sensitivity, specificity and accuracy were calculated using BinomCI (“method = Wilson”) from the R package DescTools [38]
  5. Area under ROC curve CIs were determined by bootstrapping using the R package pROC [39]
  6. CIs of the positive and negative predictive values were calculated using the R package bdpv [40] per Mercaldo et al. [41]